Clinical Infectious Diseases · 2005 · 58 citations · 16 references
Veterinary MedicineDermatologyInfectious DiseasesAntimicrobial PharmacotherapyImmunopharmacologyParasitic Skin DiseaseFungal InfectionsHuman Immunodeficiency Virus PharmacotherapyInfectious DermatosesParasitic InfectionsProtozoal InfectionsSkin InfectionsAntileishmanial ChemotherapyAntileishmanial TreatmentImmunocompromised Host ManagementImmunopathology Of LeishmaniasisLeishmaniasis Of The SkinLeishmaniasis PathogenesisLeishmaniasis PathologyTreatment Of Leishmaniasis
We describe here a case of disseminated cutaneous leishmaniasis due to Leishmania major in a severely immunocompromised patient from Burkino Faso, Africa, who is infected with human immunodeficiency virus-1. The skin lesions failed to respond to full treatment courses of amphotericin B, sodium stibogluconate, and liposomal amphotericin B but were successfully treated with miltefosine, an alkylphosphocholine analogue.
16
Oral Miltefosine for Indian Visceral Leishmaniasis
Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine · 2002 · 774 citations · Full text
Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis
T. K. Jha, Shyam Sundar, C.P. Thakur et al. · New England Journal of Medicine · 1999 · 462 citations · Full text
Trial of oral miltefosine for visceral leishmaniasis
Shyam Sundar, F. Rosenkaimer, M K Makharia et al. · The Lancet · 1998 · 245 citations · Full text
Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral Agent
Jaime Soto, Julia Toledo, P. Gutiérrez et al. · Clinical Infectious Diseases · 2001 · 225 citations